Search SAMHSA Publications and Digital Products
Store Facets Summary
- Clear all filters
- Remove Public Officials
- Remove Non-Profits & Faith-Based Organizations
- Remove People in the Juvenile Justice System
- Remove People with Co-Occurring Disorders
- Remove Hispanic or Latino
- Remove Evidence-Based Practices
- Remove Practice Guidelines
- Remove Process Improvement
- Remove Health & Health Care-Related Laws
Main page content
Published: July 2020
This issue brief presents recent data on prevalence of opioid misuse & death rates in the Hispanic/Latino population; contextual factors & challenges to prevention & treatment; innovative outreach & engagement strategies to connect people to evidence-based treatment; and the importance of community voice.
The Way Forward: Federal Action for a System That Works for All People Living With SMI and SED and Their Families and Caregivers – Full Report
Published: December 2017
This report shines the spotlight on the critical issues and services for Americans with serious mental illnesses (SMI) and serious emotional disturbances (SED), and the importance of concerted efforts by the federal government to address their needs. The report presents the current status of federal activities and a summary of advances in the care and treatment of people with SMI and SED. The report describes key advances in research and strategies to improve services to these individuals based on presentations given by the Interdepartmental Serious Mental Illness Coordinating Committee (ISMICC) members at the first ISMICC meeting.
The Way Forward: Federal Action for a System That Works for All People Living With SMI and SED and Their Families and Caregivers – Executive Summary
Published: December 2017
This Executive Summary to the 2017 report to Congress shines the spotlight on the critical issues and services for Americans with serious mental illnesses (SMI) and serious emotional disturbances (SED). The 2017 report to congress represents the starting point in a five-year process of improving the lives of people with SMI and SED. This 8-page summary delineates the five focus areas, each with 8-10 recommendations. These recommendations are from the non-federal members and represent common areas in which federal partners and stakeholders can work together to implement over the next five years.
Published: September 2014
This guide highlights the use of medication-assisted treatment (MAT) for opioid use disorder in drug courts. It reviews effective medications, including methadone, buprenorphine, and naltrexone. The guide also provides strategies to increase the use of MAT in drug court programs.